Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.20
0.120.99%
At close: -
$12.20
0.000.00%
After Hours: 4:33 PM EDT
Comments
Loading...
Zymeworks (ZYME) Forecast
NewsEarningsZymeworks (ZYME) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Zymeworks Stock Price, Quotes and Forecasts | NASDAQ:ZYME | Benzinga
Explore Zymeworks stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZYME.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zymeworks (ZYME) stock?
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Who are Zymeworks (ZYME) competitors?
Other companies in Zymeworks’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Zymeworks (ZYME) stock?
Zymeworks has a consensus price target of $16.83.
What is the current price for Zymeworks (ZYME)?
The stock price for Zymeworks (NASDAQ: ZYME) is $12.2 last updated June 4, 2025 at 4:33 PM EDT.
Does Zymeworks (ZYME) pay a dividend?
There are no upcoming dividends for Zymeworks.
When is Zymeworks (NASDAQ:ZYME) reporting earnings?
Zymeworks’s Q2 earnings are confirmed for Thursday, July 31, 2025.
Is Zymeworks (ZYME) going to split?
There is no upcoming split for Zymeworks.
What sector and industry does Zymeworks (ZYME) operate in?
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
